Suhail Allaqaband, MD
Interventional Cardiology · Milwaukee, WINPI 1669449203
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 87.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $31,314, more than ten times the $2,309 reported in 2019. Among interventional cardiology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $433.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$77K
- Abbott$4K
- Ancora Heart, Inc.$3K
- GE HealthCare$2K
- Edwards Lifesciences$2K
- Boston Scientific$258
- plus $609 from 6 others
Across 278 payments — averaging $5221.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$648K
- Abbott$351K
- Cardiovascular Systems Inc.$177K
- Boston Scientific$176K
- M.a. Med Alliance S.A.$55K
- Edwards Lifesciences$45K
What the payments were for
- Consulting fees$33,93138%
- Speaking & faculty fees$17,12519%
- Grants$70%
- Travel & lodging$30,82235%
- Food & beverage$6,5937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 140 | $77,227 |
| Abbott | 36 | $4,442 |
| Ancora Heart, Inc. | 7 | $2,722 |
| GE HealthCare | 4 | $1,632 |
| Edwards Lifesciences | 9 | $1,587 |
| Boston Scientific | 2 | $258 |
| Cardiovascular Systems Inc. | 1 | $141 |
| Heartflow, Inc. | 1 | $136 |
| Shockwave Medical, Inc | 1 | $111 |
| Corindus Inc. | 1 | $87 |
| Philips North America LLC | 1 | $74 |
| Akcea Therapeutics, Inc. | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$65,645
- CoreValve Evolut$6,515
- AccuCinch$2,712
- ALLIA$969
- MitraClip System$849
- TENDYNE$736
- Diamondback Coronary$391
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$269
- GENERAL - STRUCTURAL HEART$258
- Mitra Clip system$200
- ONYX FRONTIER$171
- MitraClip$170
- Resolute$167
- SAPIEN 3 Ultra RESILIA$157
- Coronary Orbital Atherectomy System$141
- AMPLATZER$114
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$111
How this compares
$88,477 in reported general payments places this provider in the 95th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 700 | $800,684 |
| EntrestoSacubitril/Valsartan | 345 | $474,682 |
| Repatha SureclickEvolocumab | 396 | $251,103 |
| JardianceEmpagliflozin | 200 | $235,069 |
| XareltoRivaroxaban | 96 | $119,900 |
| BrilintaTicagrelor | 106 | $84,481 |
| Praluent PenAlirocumab | 42 | $24,055 |
| VascepaIcosapent Ethyl | 28 | $22,387 |
| FarxigaDapagliflozin Propanediol | 12 | $20,385 |
| Repatha SyringeEvolocumab | 32 | $17,312 |
| ClopidogrelClopidogrel Bisulfate | 1,313 | $14,839 |
| Metoprolol Succinate | 1,139 | $14,796 |
| Atorvastatin Calcium | 1,379 | $12,770 |
| Ranolazine ErRanolazine | 77 | $6,488 |
| Rosuvastatin Calcium | 595 | $6,289 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Milwaukee
- Michael SalingerMilwaukee$216K
- Tanvir BajwaMilwaukee$106K
- Saif AnwaruddinMilwaukee$80K
- Iyad AzzamMilwaukee$60K
- Montoya TaylorMilwaukee$48K
- Mina IskanderMilwaukee$41K
- Anna LarosaMilwaukee$38K
- Louie KostopoulosMilwaukee$26K
- Daniel JohnsrudMilwaukee$25K
- Sasanka JayasuriyaMilwaukee$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.